Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting
Background: Extracellular vesicles (EVs) are attractive candidate drug delivery systems due to their ability to functionally transport biological cargo to recipient cells. However, the apparent lack of target cell specificity of exogenously administered EVs limits their therapeutic applicability. In...
Main Authors: | Sander A. A. Kooijmans, Clara Gómez Aleza, Steve R. Roffler, Wouter W. van Solinge, Pieter Vader, Raymond M. Schiffelers |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-03-01
|
Series: | Journal of Extracellular Vesicles |
Subjects: | |
Online Access: | http://www.journalofextracellularvesicles.net/index.php/jev/article/view/31053/pdf_48 |
Similar Items
-
GPI-anchored protein organization and dynamics at the cell surface
by: Suvrajit Saha, et al.
Published: (2016-02-01) -
GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets
by: Nada H. Hussein, et al.
Published: (2020-12-01) -
Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes
by: Leigh C. Carmody, et al.
Published: (2020-02-01) -
Thematic Review Series: Glycosylphosphatidylinositol (GPI) Anchors: Biochemistry and Cell Biology Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling
by: Taroh Kinoshita, et al.
Published: (2016-01-01) -
Implications of lipid moiety in oligomerization and immunoreactivities of GPI-anchored proteins
by: Jihyoun Seong, et al.
Published: (2013-04-01)